COMMUNIQUÉS West-GlobeNewswire

Mustang Bio Announces Proposed Public Offering of Common Stock

29/04/2019 - 22:01

NEW YORK, April 29, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into [...]

SunGen Pharma Receives its Fourth and Fifth ANDA Approvals from US FDA

29/04/2019 - 20:50

PRINCETON, N.J., April 29, 2019 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced it [...]

IRIDEX’s MicroPulse® Laser Technology Featured in Several Glaucoma and Retina Research Presentations at Major Ophthalmic Industry Conferences

29/04/2019 - 20:41

MOUNTAIN VIEW, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced [...]

Innovate Biopharmaceuticals Announces $8.7 Million Registered Direct Offering Priced At-the-Market

29/04/2019 - 19:19

RALEIGH, N.C., April 29, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT) today announced that it has entered into securities purchase agreements with certain institutional investors providing [...]

Emendo Biotherapeutics Enters Into Licensing Option Agreement With Takeda for its OMNI Nuclease Program

29/04/2019 - 19:11

NEW YORK, April 29, 2019 (GLOBE NEWSWIRE) -- Emendo Biotherapeutics Inc. today announced that the company signed a licensing option agreement with Takeda Pharmaceutical Company Limited. As part of the transaction, [...]

Trading by management and close relations of management

29/04/2019 - 19:04

Please read the full announcement in PDF Attachment 2019_10_Trading_by_management_EN

Agreement between Novozymes and Novo Holdings A/S on trading of shares as part of Novozymes share buyback program

29/04/2019 - 19:00

Please read the full announcement in PDF Attachment 2019_09_Novo_Holding_stock_buyback_program_EN

Ronald McDonald House Charities Announces Winners of the 2019 Remarkable Impact Grants

29/04/2019 - 18:28

Through tremendous support from AbbVie, winning Chapters will receive funding to support enhanced family-centered services, deepening the impact on families and connections within the community CHICAGO, April 29, 2019 ( [...]

Lawsuit against NYC Vaccine Order Dismissed, States Association of American Physicians and Surgeons (AAPS)

29/04/2019 - 18:08

TUCSON, Ariz., April 29, 2019 (GLOBE NEWSWIRE) -- Brooklyn Judge Lawrence Knipel has dismissed a lawsuit ( C.F. v. NYC Health Commissioner ) brought by five mothers against Mayor Bill de Blasio’s emergency order [...]

Ossur Hf : Transactions in relation to share buyback program

29/04/2019 - 18:01

Announcement no. 27/2019 29 April 2019 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]

Spineway : 2018 annual results

29/04/2019 - 17:45

2018 annual results Implementation of the NEWWAY 2021 plan Strategic acquisition in Latin America In thousands of euros Consolidated accounts 2018 2017 Revenue 6 515 9 138 Gross margin % of revenue 4 201 64.5% 6 151 67. [...]

SPINEWAY : Résultats annuels 2018

29/04/2019 - 17:45

Résultats annuels 2018 Déploiement du plan NEWWAY 2021 Acquisition stratégique en Amérique Latine En Milliers d'euros Comptes consolidés 2018 2017 Chiffre d'affaires 6 515 9 138 Marge Brute % CA 4 201 64,5% 6 151 67,3% [...]

Exactus Initiates Operations on Two 100-Acre SW Oregon Industrial Hemp Farms

29/04/2019 - 17:41

Receives Positive Results from an Independent Fairness Opinion Conducted for Exactus’ Acquisition of 50.1% of Exactus One World, LLC DELRAY BEACH, Fla., April 29, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB: EXDI) (the [...]

Transactions under Novozymes’ stock buyback program

29/04/2019 - 16:57

Please read the full announcement in the attached PDF Attachment 2019_08_Stock_Buybackprogram_EN

Announcement of redemption of remaining shares in NeuroSearch A/S under sections 70-72 of the Danish Companies Act as part of reversed share split at consolidation ratio 20:1

29/04/2019 - 16:27

Company announcement 29 April 2019 At the company’s annual general meeting on 29 April 2019 it was decided to amend the nominal value of the company's shares from DKK 0.05 and any multiple thereof to DKK 1 and any [...]

CORRECTION: Information regarding acquisition or disposal of a major holding

29/04/2019 - 15:52

Notices specified as attached: Notice of disposal of major holding by Kirovs Lipmans Notice of disposal of major holding by Anna Lipmane Notice of acquisition of direct major holding by “Liplat Holding” Ltd. Notice of [...]

BioRestorative Therapies to Present at the 22nd Annual American Society of Gene and Cell Therapy as to Data on its Platform Technology for the Treatment of Metabolic Disorders

29/04/2019 - 15:45

Cell Based Therapy for the Treatment of Type 2 Diabetes, Obesity, Hyperlipidemia and Hypertension MELVILLE, N.Y., April 29, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") ( [...]

Allergan and Editas Medicine Announce Initial Data from Natural History Study to Evaluate Patients with Leber Congenital Amaurosis 10 (LCA10)

29/04/2019 - 15:19

DUBLIN, Ireland and CAMBRIDGE, Mass., April 29, 2019 (GLOBE NEWSWIRE) -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, [...]

Novo Nordisk A/S - Share repurchase programme

29/04/2019 - 15:03

Bagsværd, Denmark, 29 April 2019 - On 1 February 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]